Epithelial cell biocompatibility of silica nanospheres for contrast-enhanced ultrasound molecular imaging

Journal of Nanoparticle Research

Volumn 15, Issue 7, 2013, Pages

  Chiriacò, Fernanda ^a   Conversano, Francesco ^a   Soloperto, Giulia ^a   Casciaro, Ernesto ^a   Ragusa, Andrea ^b   Sbenaglia, Enzo Antonio ^a   Dipaola, Lucia ^a   Casciaro, Sergio ^c  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b NATIONAL NANOTECHNOLOGY LABORATORY   (Italy)

^c CNR   (Italy)

Author keywords

Biological techniques; Biomedical materials; Cancer detection; Cells (biology); Medical diagnostic imaging; Molecular imaging; Nanobiotechnology; Nanoparticles; Toxicity

Indexed keywords

BIOCOMPATIBILITY; BIOMEDICAL MATERIALS; CELL CULTURE; CELLS; DIAGNOSIS; DISEASES; LANTHANUM COMPOUNDS; NANOBIOTECHNOLOGY; NANOPARTICLES; NANOSPHERES; PARTICLE SIZE; SILICA; SILICON; TOXICITY; ULTRASONIC APPLICATIONS;

BIOLOGICAL RECOGNITION; BIOLOGICAL TECHNIQUES; CANCER DETECTION; CONTRAST ENHANCED ULTRASOUND; CONTRAST ENHANCEMENT; MEDICAL DIAGNOSTIC IMAGING; NANO-SIZED PARTICLES; RETICULOENDOTHELIAL SYSTEMS;

MOLECULAR IMAGING;

ECHO CONTRAST MEDIUM; NANOSPHERE; SILICA NANOSPHERE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CELL STRAIN MCF 7; CELL VIABILITY; CONCENTRATION RESPONSE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG CYTOTOXICITY; ECHOGRAPHY; EPITHELIUM CELL; FEMALE; HELA CELL; HUMAN; HUMAN CELL; MOLECULAR IMAGING; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 84878816230     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-1779-y     Document Type: Article

References (51)

1. Barbe C, Bartlet J, Kong L, Finnie K, Lin HQ, Larkin M, Calleja S, Bush A, Calleja G (2004) Silica particles: a novel drug delivery system. Adv Mater 16:1959-1966
2. Buchanan KD, Huang S, Kim H, Macdonald RC, McPherson DD (2008) Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature. J Pharm Sci 97:2242-2249
3. Casciaro S (2011) Theranostic applications: non-ionizing cellular and molecular imaging through innovative nanosystems for early diagnosis and therapy. World J Radiol 3:249-255
4. Casciaro S, Palmizio Errico R, Conversano F, Demitri C, Distante A (2007) Experimental investigations of nonlinearities and destruction mechanisms of an experimental phospholipid-based ultrasound contrast agent. Invest Radiol 42:95-104 (Pubitemid 46104890)
5. Casciaro S, Conversano F, Ragusa A, Malvindi MA, Franchini R, Greco A, Pellegrino T, Gigli G (2010) Optimal enhancement configuration of silica nanoparticles for US imaging and automatic detection at conventional diagnostic frequencies. Invest Radiol 45:715-724
6. Casciaro S, Soloperto G, Greco A, Casciaro E, Franchini R, Conversano F (2013) Effectiveness of functionalized nanosystems for multimodal molecular sensing and imaging in medicine. IEEE Sens J 13:2305-2312
7. Chang JS, Chang KL, Hwang DF, Kong ZL (2007) In vitro cytotoxicity of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ Sci Technol 41:2064-2068 (Pubitemid 46449243)
8. Cho EC, Glaus C, Chen J, Welch MJ, Xia Y (2010) Inorganic nanoparticle-based contrast agents for molecular imaging. Trends Mol Med 16:561-573
9. Conversano F, Franchini R, Lay-Ekuakille A, Casciaro S (2012a) In vitro evaluation and theoretical modeling of the dissolution behavior of a microbubble contrast agent for US imaging. IEEE Sens J12:496-503
10. Conversano F, Greco A, Casciaro E, Ragusa A, Lay-Ekuakille A, Casciaro S (2012b) Harmonic US imaging of nanosized contrast agents for multimodal molecular diagnoses. IEEE Trans Instrum Meas 61:1848-1856
11. Conversano F, Soloperto G, Greco A, Ragusa A, Casciaro E, Chiriacò F, Demitri C, Gigli G, Maffezzoli A, Casciaro S (2012c) Ecographic detectability of optoacoustic signals from low-concentration PEG-coated gold nanorods. Int J Nanomed 7:4373-4389
12. Dayton PA, Rychak JJ (2007) Molecular US imaging using microbubble contrast agents. Front Biosci 12:5124-5142
13. Dayton PA, Zhao S, Bloch SH, Schumann P, Penrose K, Matsunaga TO, Zutshi R, Doinikov A, Ferrara KW (2006) Application of ultrasound to selectively localize nanodroplets for targeted imaging and therapy. Mol Imaging 5:160-174
14. Dipaola L, Chiriacò F, Sbenaglia EA, Conversano F, Ragusa A, Casciaro S (2011) Cytotoxicity assessment of silica-based nanosized contrast agents for US molecular imaging. In: Proceedings of the IEEE sensors conference October 28-31. Limerick, Ireland
15. Fajaroha F, Setyawanb H, Nur A, Lenggoroc IV (2013) Thermal stability of silica-coated magnetite nanoparticles prepared by an electrochemical method. Adv Powder Technol 24:507-511
16. Faure AC, Dufort S, Josserand V, Perriat P, Coll JL, Roux S, Tillement O (2009) Control of the in vivo biodistribution of hybrid nanoparticles with different poly(ethylene glycol) coatings. Small 5:2565-2575
17. Greaby R, Zderic V, Vaezy S (2007) Pulsatile flow phantom for US image-guided HIFU treatment of vascular injuries. US Med Biol 33:1269-1276 (Pubitemid 47102526)
18. Hahn MA, Singh AK, Sharma P, Brown SC, Moudgil BM (2011) Nanoparticles as contrast agents for in vivo bioimaging: current status and future perspectives. Anal Bioanal Chem 399:3-27
19. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci 95:4607-4612 (Pubitemid 28207960)
20. Iyer AK, Khaled G, Fang J, Maeda H (2006) Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 11:812-818 (Pubitemid 44280021)
21. Larsen EK, Nielsen T, Wittenborn T, Birkedal H, Vorup-Jensen T, Jakobsen MH, Ostergaard L, Horsman MR, Besenbacher F, Howard KA, Kjems J (2009) Size-dependent accumulation of PEGylated silane-coated magnetic iron oxide nanoparticles in murine tumors. ACS Nano 3:1947-1951
22. Liu J, Levine AL, Mattoon JS, Yamaguchi M, Lee RJ, Pan X, Rosol TJ (2006) Nanoparticles as image enhancing agents for ultrasonography. Phys Med Biol 51:2179-2189
23. Liu J, Li J, Rosol TJ, Pan X, Voorhees JL (2007) Biodegradable nanoparticles for targeted ultrasound imaging of breast cancer cells in vitro. Phys Med Biol 52:4739-4747 (Pubitemid 47232284)
24. Lutz JF, Stiller S, Hoth A, Kaufner L, Pison U, Cartier R (2006) One-pot synthesis of pegylated ultrasmall iron-oxide nanoparticles and their in vivo evaluation as magnetic resonance imaging contrast agents. Biomacromolecules 7:3132-3138 (Pubitemid 46039971)
25. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271-284 (Pubitemid 30122932)
26. Malugin A, Herd H, Ghandehari H (2011) Differential toxicity of amorphous silica nanoparticles toward phagocytic and epithelial cells. J Nanopart Res 13:5381-5396
27. Malvindi MA, Greco A, Conversano F, Figuerola A, Corti M, Bonora M, Lascialfari A, Doumari HA, Moscardini M, Cingolani R, Gigli G, Casciaro S, Pellegrino T, Ragusa A (2011) Magnetic/silica nanocomposites as dual-mode contrast agents for combined magnetic resonance imaging and ultrasonography. Adv Funct Mater 21:2548-2555
28. Marquis BJ, Love SA, Braun KL, Haynes CL (2009) Analytical methods to assess nanoparticle toxicity. Analyst 134:425-439
29. Masotti L, Biagi E, Scabia M, Acquafresca A, Facchini R, Ricci A, Bini D (2006) FEMMINA real-time, radio-frequency echo-signal equipment for testing novel investigation methods. IEEE Trans Ultrason Ferroelectr Freq Control 53:1783-1795 (Pubitemid 44946555)
30. Napierska D, Thomassen LCJ, Lison D, Martens JA, Hoet PH (2010) The nanosilica hazard: another variable entity. Part Fibre Toxicol 7:39
31. Park MVDZ, Lynch I, Ramírez-García S, Dawson KA, de la Fonteyne L, Gremmer E, Slob W, Briedé JJ, Elsaesser A, Howard CV, van Loveren H, de Jong WH (2011) In vitro evaluation of cytotoxic and inflammatory properties of silica nanoparticles of different sizes in murine RAW 264.7 macrophages. J Nanopart Res 13:6775-6787
32. Pascali G, Conversano F, Casciaro S, Salvadori P (2012) A translational perspectives in molecular imaging: methodological evolution and nanostructured materials. Recenti Prog Med 103:142-153
33. Prabhu P, Patravale V (2012) The upcoming field of theranostic nanomedicine: an overview. J Biomed Nanotechnol 8:859-882
34. Rabolli V, Thomassen LC, Princen C, Napierska D, Gonzales L, Kirsch-Volders M, Hoet PH, Huaux F, Kirschhock CE, Martens JA, Lison D (2010) Influence of size, surface area and microporosity on the in vitro cytotoxic activity of amorphous silica nanoparticles in different cell types. Nanotoxicology 4:307-318
35. Rasaneh S, Rajabi H, Babaei MH, Akhlaghpoor S (2011) MRI contrast agent for molecular imaging of the HER2/neu receptor using targeted magnetic nanoparticles. J Nanopart Res 13:2285-2293
36. Rawashdeh WA, Kray S, Pich A, Pargen S, Balaceanu A, Lenz M, Spöler F, Kiessling F, Lederle W (2012) Polymeric nanoparticles as OCT contrast agents. J Nanopart Res 14:1255
37. Roy I, Ohulchanskyy TY, Bharali DJ, Pudavar HE, Mistretta RA, Kaur N, Prasad PN (2011) Optical tracking of organically modified silica nanoparticles as DNA carriers: a nonviral, nanomedicine approach for gene delivery. Proc Natl Acad Sci USA 102:279-284
38. Shan L, Chopra A, Leung K, Eckelman WC, Menkens AE (2012) Characterization of nanoparticle-based contrast agents for molecular magnetic resonance imaging. J Nanopart Res 14:1122
39. Sirsi S, Feshitan J, Kwan J, Homma S, Borden M (2010) Effect of microbubble size on fundamental mode high frequency ultrasound imaging in mice. Ultrasound Med Biol 36:935-948
40. Soloperto G, Casciaro S (2012) Progress in atherosclerotic plaque imaging. World J Radiol 4(353):371
41. Stober W, Fink A, Bohn E (1968) Controlled growth of mono-disperse silica sphere in the micron size range. J Colloid Interface Sci 26:62-69
42. Tasciotti E, Liu X, Bhavane R, Plant K, Leonard AD, Price BK, Cheng MM, Decuzzi P, Tour JM, Robertson F, Ferrari M (2008) Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol 3:151-157 (Pubitemid 351355132)
43. Thomassen LC, Aerst A, Rabolli V, Lison D, Gonzalez L, Kirsch-Volders M, Napierska D, Hoet PH, Kirschhock CE, Martens JA (2010) Synthesis and characterization of stable monodisperse silica nanoparticle sols for in vitro cytotoxicity testing. Langmuir 26:328-335
44. Tromsdorf UI, Bruns OT, Salmen SC, Beisiegel U, Weller H (2009) A highly effective, nontoxic T1 MR contrast agent based on ultrasmall PEGylated iron oxide nanoparticles. Nano Lett 9:4434-4440
45. Van Vlerken LE, Vyas TK, Amiji MM (2007) Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res 49:1405-1414 (Pubitemid 46988224)
46. Wang L, Yang C, Tan W (2005) Dual-luminophore-doped silica nanoparticles for multiplexed signaling. Nano Lett 5:37-43 (Pubitemid 40168900)
47. Wang L, Wang K, Santra S, Zhao X, Hilliard LR, Smith JE, Wu Y, Tan W (2006) Watching silica nanoparticles glow in the biological world. Anal Chem 78:646-654 (Pubitemid 43228570)
48. Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219:316-333 (Pubitemid 32336342)
49. Wheatley MA, Forsberg F, Dube N, Patel M, Oeffinger BE (2006) Surfactant-stabilized contrast agent on the nanoscale for diagnostic ultrasound imaging. Ultrasound Med Biol 32:83-93 (Pubitemid 41814864)
50. Yu KO, Grabinski CM, Schrand AM, Murdock RC, Wang W, Gu B, Schlager JJ, Hussain SM (2009) Toxicity of amorphous silica nanoparticles in mouse keratinocytes. J Nanopart Res 11:15-24
51. Zhu Y, Fang Y, Borchardt L, Kaskel S (2011) PEGylated hollow mesoporous silica nanoparticles as potential drug delivery vehicles. Microp Mesop Mater 141:199-206